Improving the quality of hospital services in The Netherlands. The role of CBO--The National Organization for Quality Assurance in The Netherlands

Quality Assurance in Health Care : the Official Journal of the International Society for Quality Assurance in Health Care
E Reerink

Abstract

In The Netherlands, quality assurance activities in hospitals began in 1976 with a formal declaration of the National Specialists Organization that quality assurance is a task of the medical profession. It was also recognized that physicians in hospitals were as yet unable to execute the various tasks that come with formal quality assurance. Hence the creation of a support organization that would assist clinicians in taking up and fulfilling their commitment to quality assurance. The creation of CBO took place in 1979; its role has been expanded to encompass such functions as technical assistance, education and training, research and development, acting as a clearing-house, and providing a forum. CBO has recently obtained an additional function; acting as a role model for similar structures in other countries in Europe and on other continents. A network of support organizations has been formed through which the development of quality assurance in health care is furthered.

Citations

Dec 9, 1994·International Journal of Health Care Quality Assurance·R Eldar, R Ronen
Jul 19, 2001·International Clinical Psychopharmacology·W KisslingK Piwernetz
Jun 15, 1991·BMJ : British Medical Journal·E Reerink
Jan 1, 1997·The Joint Commission Journal on Quality Improvement·J Ovretveit

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.